Andere Sprachen Sanara MedTech Inc.

Aktien

A2PKM6

US79957L1008

SMTI

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 01.05.2024			% 5 Tage	% 1. Jan.
31,23 ^USD	-1,92 %		-3,91 %	-24,01 %

05.04.	Sanara MedTech ernennt Jake Waldrop zum Chief Operating Officer	MT
05.04.	Sanara MedTech Inc. kündigt Änderungen in der Geschäftsführung an, die am 15. April 2024 in Kraft treten	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Sanara MedTech Inc. Announces First Quarter Earnings Release and Conference Call Dates	29.04.
Sanara MedTech Inc. Announces $55 Million Debt Facility	18.04.
Sanara Medtech Inc. Announces $55 Million Debt Facility	18.04.
Sanara MedTech Appoints Jake Waldrop as Chief Operating Officer	05.04.
Sanara MedTech Inc. Announces the Appointments of Jake Waldrop as Chief Operating Officer and Tyler Palmer as Chief Corporate Development and Strategy Officer	05.04.
Sanara MedTech Inc. Announces Executive Changes, Effective April 15, 2024	05.04.
Earnings Flash (SMTI) SANARA MEDTECH Posts Q4 Revenue $17.7M, vs. Street Est of $16.5M	25.03.
Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 Results	25.03.
Sanara MedTech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	25.03.
Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 Earnings Release and Conference Call Dates	13.03.
Sanara MedTech Reports Higher Preliminary Q4 Revenue	22.02.
Sanara MedTech Inc. Announces Unaudited Preliminary Results for the Fourth Quarter and Full Year 2023	22.02.
Sanara MedTech Inc. Announces Unaudited Preliminary Net Revenue Results for the Fourth Quarter and Full-Year 2023	22.02.
Sanara MedTech Inc. Announces Exclusive License Agreement for Patented Collagen Peptides	03.01.
Sanara MedTech Secures Exclusive Licensing Deal with Tufts University for 18 Collagen Peptides	03.01.
Sanara MedTech Inc. Announces the Publication of a 5,335 Patient Study Demonstrating a Significant Reduction in Surgical Site Infections When Activated Collagen (CellerateRX® Surgical Powder) Was Used to Promote Wound Healing	30.11.
Sanara MedTech Q3 Loss Narrows, Revenue Rises; Shares Fall After Hours	13.11.
Sanara MedTech Inc. Announces Third Quarter 2023 Results	13.11.
Earnings Flash (SMTI) SANARA MEDTECH Reports Q3 Revenue $16M, vs. Street Est of $18.8M	13.11.
Sanara MedTech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13.11.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Sanara MedTech Inc.

Aktien

A2PKM6

US79957L1008

SMTI

Andere Sprachen

Filter